Swedish Mesothelioma Rates Unaffected By Asbestos Ban


The asbestos ban instituted in Sweden more than 30 years ago had still not had any measurable impact on the incidence of malignant mesothelioma in the country as of 2009. That is the conclusion reached by researchers at Sweden’s Institute of Environmental Medicine at the Karolinska Institute in Stockholm who just completed a major study of […]

Asbestos-Related T-Cell Changes Help Explain Mesothelioma Development


Researchers in Japan have taken another step toward understanding how asbestos causes malignant mesothelioma. Exposure to airborne asbestos fibers is the leading cause of malignant mesothelioma worldwide, but scientists are still unclear on exactly what makes healthy mesothelial cells in the membranes around organs give rise to mesothelioma tumors. Now, scientists at Kawasaki Medical School […]

New Clinical Trial Aims to Create Bioresource for Improved Mesothelioma Diagnosis


Malignant mesothelioma is not only one of the rarest and most difficult-to-treat cancers. It is also among the hardest to diagnose. The challenge of diagnosing the asbestos cancer can lead to delayed referral and late treatment and can limit mesothelioma patients’ access to clinical trials that might help them. In an effort to improve the […]

New Mesothelioma Immunotherapies Target Key Protein


The cell-surface glycoprotein mesothelin is poised to be a key part of several new immunotherapy approaches for the treatment of malignant pleural mesothelioma, a treatment-resistant cancer caused by asbestos. A team of top mesothelioma researchers with the National Cancer Institute’s Center for Cancer Research recently published their analysis of several ongoing studies of therapies that target […]

Psychological Needs of Mesothelioma Patients Differ from Lung Cancer


New research suggests that, even though pleural mesothelioma is considered a type of lung cancer, people with the asbestos cancer are likely to face some different stresses and concerns from lung cancer patients. Pleural mesothelioma grows on the pleural membrane that surrounds the lungs. It is almost always caused by past exposure to asbestos dust, […]

Platelet Count May be an Effective Tool for Mesothelioma Prognosis

2105823_blood test5

A high platelet count may not bode well for people battling malignant pleural mesothelioma. New evidence suggests that people who have a high concentration of platelets in their blood prior to the start of mesothelioma treatment have shorter overall survival than those with normal platelet counts. The news comes from a Chinese meta-analysis including more […]

Study Finds Chemotherapy Maximizes Odds of Mesothelioma Survival

919316_chemo drug

A large US study of mesothelioma patients confirms what other studies have suggested: Mesothelioma patients who have chemotherapy live longer than those who don’t, and multimodal therapy is the best way to improve overall mesothelioma survival. The study utilized data from the National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER) database and included 1,625 […]

Multi-Modal Mesothelioma Treatment Leads to Three-Year Survival


There has been some encouraging news this month for patients suffering from an aggressive form of lung cancer called malignant pleural mesothelioma. New research suggests that, even in patients with advanced mesothelioma, long-term survival is possible with a strategic multi-modal approach. The Research The new mesothelioma study, conducted at several US medical centers and published […]

Mesothelioma Risk Among Seaman and Sailors Still Hard to Quantify

310188_Navy Ship small

  Thousands of people who worked aboard commercial ships may be at higher risk for developing malignant mesothelioma. Unfortunately, although the mesothelioma risk for merchant seamen has been acknowledged since the 1970s, there is still little information on how high the risk may be. That news comes from a new report on commercial seamen and […]

Measuring Mesothelioma Treatment Response with Biomarkers

2516827_blood test

Malignant pleural mesothelioma is notoriously difficult to treat and doctors often have to try different treatment combinations to produce a response. But how can they know if a particular treatment strategy is working? A team of researchers in Pisa, Italy suggest that three key biomarkers may be the answer. Soluble mesothelin-related peptides (SMRP), plasma osteopontin […]